Cargando…
Assessment of Manganese-Zinc Ferrite Nanoparticles as a Novel Magnetic Resonance Imaging Contrast Agent for the Detection of 4T1 Breast Cancer Cells
BACKGROUND: The aim of the study was to evaluate the potential of manganese-zinc ferrite nanoparticles (MZF NPs) as a novel negative magnetic resonance imaging (MRI) contrast agents for 4T1 (mouse mammary carcinoma) and L929 (murine fibroblast) cell lines. METHODS: MZF NPs and its suitable coating,...
Autores principales: | Sobhani, Tayebe, Shahbazi-Gahrouei, Daryoush, Rostami, Mahboubeh, Zahraei, Maryam, Farzadniya, Amin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839441/ https://www.ncbi.nlm.nih.gov/pubmed/31737553 http://dx.doi.org/10.4103/jmss.JMSS_59_18 |
Ejemplares similares
-
Chitosan–Imidazolium Core–Shell Nanoparticles of Gd-Mn-Mo Polyoxometalate as Novel Potential MRI Nano-Agent for Breast Cancer Detection
por: Aminolroayaei, Fahimeh, et al.
Publicado: (2023) -
Cobalt Zinc Ferrite Nanoparticles as a Potential Magnetic Resonance Imaging Agent: An In vitro Study
por: Ghasemian, Zeinab, et al.
Publicado: (2015) -
Novel MR imaging contrast agents for cancer detection
por: Shahbazi-Gahrouei, Daryoush
Publicado: (2009) -
Synthesis and Application of Fe(3)O(4)@Au Composite Nanoparticles as Magnetic Resonance/Computed Tomography Dual-Modality Contrast Agent
por: Keshtkar, Mohammad, et al.
Publicado: (2020) -
Aptamer-conjugated Magnetic Nanoparticles as Targeted Magnetic Resonance Imaging Contrast Agent for Breast Cancer
por: Keshtkar, Mohammad, et al.
Publicado: (2016)